What side effects are associated with this type of intervention?

Common treatments for stuttering include speech therapy, cognitive-behavioral therapy (CBT), and medications such as SSRIs or antipsychotics. Speech therapy and CBT are generally well-tolerated with minimal side effects, though some individuals may experience anxiety or frustration during therapy sessions. Medications like SSRIs can cause side effects such as nausea, headache, sleep disturbances, and sexual dysfunction, while antipsychotics may lead to weight gain, drowsiness, and extrapyramidal symptoms (movement disorders).

What prior FDA approvals exist?

There are no specific FDA-approved medications for the treatment of stuttering. Current treatments primarily focus on speech therapy and behavioral interventions. The clinical trial on rhythm perception and production tasks aims to explore non-pharmacological methods by assessing task performance and its correlation with brain activity, which may offer new insights into stuttering management.

What other types of research exist?

Promising, novel alternatives for stuttering treatment in 2024 include the use of brain-computer interfaces (BCIs) combined with virtual reality (VR) for cognitive and motor imagery tasks. These technologies can help in training speech production and fluency by providing real-time feedback and immersive environments. Additionally, sound-imagery tasks for onset detection in self-paced BCIs could be adapted to improve speech initiation and control in stuttering patients.

← Back to Search

Rhythm Perception Training for Stuttering

N/A

Recruiting

Led By Soo-Eun Chang, PhD

Research Sponsored by University of Michigan

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Children who stutter: Current or past stuttering diagnosis

Be younger than 18 years old

Must not have

Children who do not stutter: Face, motor, or reflex abnormalities

Children who stutter: Face, motor, or reflex abnormalities

Timeline

Screening 3 weeks

Treatment Varies

Follow Up year 3

Awards & highlights

No Placebo-Only Group

Summary

This trial involves children listening to rhythms and tapping their fingers to see if there are differences between those who stutter and those who do not.

Who is the study for?

This trial is for children who currently or previously had a stutter and speak English as their primary language. It's not suitable for kids with hearing loss, significant language/motor delays, head trauma with unconsciousness, major medical illnesses, neurological/psychiatric conditions under treatment, or certain facial/motor abnormalities.

What is being tested?

The study is examining how well children who stutter and those who don't can perceive and produce rhythms. The goal is to understand the relationship between rhythm tasks performance and brain activity in these groups.

What are the potential side effects?

Since this trial involves non-invasive rhythm discrimination tasks without any medication or clinical intervention, there are no expected side effects related to the activities performed during the study.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have been diagnosed with stuttering, now or in the past.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

My child does not stutter and has no face, motor, or reflex abnormalities.

Select...

My child stutters and has physical abnormalities.

Select...

I am a child who stutters and I have a serious health condition.

Select...

My child stutters and has a diagnosed neurological or psychiatric condition.

Select...

My child does not stutter and has no diagnosed neurological or psychiatric conditions.

Select...

My child has had a head injury with unconsciousness and stutters.

Select...

My child does not stutter and has a major medical illness.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ year 3

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~year 3

This trial's timeline: 3 weeks for screening, Varies for treatment, and year 3 for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Rhythm discrimination (d')

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Children who stutterExperimental Treatment1 Intervention

Children who stutter

Group II: Children who do not stutterExperimental Treatment1 Intervention

Children who do not stutter

0 / 8Eligibility criteria met

Research Highlights

Information in this section is not a recommendation. We encourage patients to speak with their healthcare team when evaluating any treatment decision.

Mechanism Of Action

Side Effect Profile

Prior Approvals

Other Research

Common treatments for stuttering include speech therapy, cognitive-behavioral therapy, and non-invasive brain stimulation techniques. Speech therapy often involves exercises to improve fluency, such as controlled breathing and gradual progression from single words to complex sentences. Cognitive-behavioral therapy addresses the psychological aspects of stuttering, helping patients manage anxiety and negative thoughts. Non-invasive brain stimulation, such as transcranial magnetic stimulation (TMS), aims to modulate brain activity to improve speech fluency. The study of rhythm perception and production tasks is particularly relevant as it explores how timing and coordination in speech are processed in the brain. Understanding these mechanisms can help tailor more effective treatments, potentially leading to better outcomes for stuttering patients by targeting the specific neural pathways involved in speech production.

Effects of repetitive transcranial magnetic stimulation with different frequencies on post-stroke aphasia: A PRISMA-compliant meta-analysis.Non-invasive brain stimulation as add-on therapy for subacute post-stroke aphasia: a randomized trial (NORTHSTAR).Music interventions for acquired brain injury.